Publication detail

Surface antibodies-modification of apoferritin with encapsulated doxorubicin favorably influences the formation of protein corona

DOSTÁLOVÁ, S. POMPEIANO VANÍČKOVÁ, L. GURÁŇ, R. ZÍTKA, O. HYNEK, D. ADAM, V. HEGER, Z.

Original Title

Surface antibodies-modification of apoferritin with encapsulated doxorubicin favorably influences the formation of protein corona

Type

abstract

Language

English

Original Abstract

Nano-sized carriers can encapsulate anticancer drugs and deliver them to the tumor tissue. Upon entering the blood stream, many nanocarriers get covered by protein corona, hampering their entry to target cells. Thus, we aimed to study the protein corona formation around bare and Abs-modified apoferritin bearing doxorubicin.

Keywords

Nanocarriers; anticancer drugs; doxorubicin; apoferritin

Authors

DOSTÁLOVÁ, S.; POMPEIANO VANÍČKOVÁ, L.; GURÁŇ, R.; ZÍTKA, O.; HYNEK, D.; ADAM, V.; HEGER, Z.

Released

30. 11. 2016

Publisher

Institute of molecular and translational medicine

Location

Olomouc, Czech Republic

ISBN

978-80-270-0464-5

Book

XII. Diagnostic, Predictive and Experimental Oncology Days

Pages from

37

Pages to

37

Pages count

1

BibTex

@misc{BUT133562,
  author="Simona {Dostálová} and Lucie {Pompeiano Vaníčková} and Roman {Guráň} and Ondřej {Zítka} and David {Hynek} and Vojtěch {Adam} and Zbyněk {Heger}",
  title="Surface antibodies-modification of apoferritin with encapsulated doxorubicin favorably influences the formation of protein corona",
  booktitle="XII. Diagnostic, Predictive and Experimental Oncology Days",
  year="2016",
  pages="37--37",
  publisher="Institute of molecular and translational medicine",
  address="Olomouc, Czech Republic",
  isbn="978-80-270-0464-5",
  note="abstract"
}